Advertisement
Collaboration › Details
Bruker–Leucadia: investor conference, 201906 supply service Bruker presents at Jefferies Healthcare Conference in New York
Period | 2019-06-06 | |
Region | New York, NY | |
Country | United States (USA) | |
Partner, 1st | Bruker Corporation (Nasdaq: BRKR) | |
Group | Bruker (Group) | |
Partner, 2nd | Jefferies Group Inc. | |
Today | Jefferies LLC | |
Group | Leucadia (Group) | |
Product | Jefferies 2019 Global Healthcare Conference New York | |
Product 2 | analytical instrument | |
Person | Laukien, Frank H. (Bruker 201204 President + CEO) | |
Person 2 | Srega, Jürgen (Bruker 201302– President Bruker CALID Group before BRAHMS + Thermo Fisher Bremen) | |
Bruker Corporation. (5/28/19). "Press Release: Bruker Corporation to Present at Jefferies 2019 Global Healthcare Conference". Billerica, MA.
Bruker Corporation (Nasdaq: BRKR) announced today that it will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in New York on Thursday, June 6, 2019 at 4:00 pm EDT. Presenting for the company will be Frank Laukien, President and Chief Executive Officer, and Juergen Srega, President, Bruker CALID Group.
A live audio webcast of the event will be available on the Investor Relations section of the Company's Web site at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
Contact :
Pam Clark
Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext.1479
E: investor.relations@bruker.com
Record changed: 2019-12-10 |
Advertisement
More documents for Bruker (Group)
- [1] Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan....
- [2] Bruker Corporation. (3/16/22). "Press Release: Bruker Appoints Philip Ma to Its Board of Directors". Billerica, MA....
- [3] IsoPlexis. (1/7/21). "Press Release: IsoPlexis Announces $135 Million Financing Led by Perceptive Advisors". Branford, CT....
- [4] Syft Technologies Ltd.. (12/16/20). "Press Release: Syft Appoints a VP of Sales - Europe"....
- [5] Biognosys AG. (8/8/19). "Press Release: Biognosys Completes Series G Financing Round to Accelerate its Expansion into Clinical Trials Market". Schlieren....
- [6] Selexis S.A.. (3/28/19). "Press Release: Selexis Bolsters Business Development Team to Support Expanding Base of Partners Relying on Its SUREtechnology to Advance Complex Biologics and Vaccines". Geneva....
- [7] Bruker Corporation. (12/31/17). "Press Release: Bruker Announces Merger of Japan Subsidiaries". Yokohama....
- [8] Bruker Corporation. (9/6/17). "Press Release: Bruker Announces the New D8 Discover Plus XRD System". Chiba....
- [9] Bruker Corporation. (3/29/17). "Press Release: Signaling Continued Investment in China, Bruker Open Beijing Center of Excellence". Beijing....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top